Ironwood Pharmaceuticals | IRWD - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals reported $396.65M in Loan Capital for its fiscal quarter ending in March of 2023.


Loan Capital Change
Akebia Therapeutics AKBA:US USD 26.3M 7.78M
Almirall SA ALM:SM EUR 387.16M 13.66M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Astellas Pharma 4503:JP JPY 139.92B 8.81B
AstraZeneca AZN:LN USD 27.65B 3.96B
Charles River Laboratories CRL:US USD 2.74B 36.24M
Esperion Therapeutics ESPR:US USD 260.32M 417K
Exact Sciences EXAS:US USD 2.37B 123.49M
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Incyte Corp INCY:US USD 29.7M 384K
Intercept Pharmaceuticals ICPT:US USD 223.35M 248K
Ironwood Pharmaceuticals IRWD:US USD 396.65M 402K
Karyopharm Therapeutics KPTI:US USD 303.02M 201K
Moderna Inc MRNA:US USD 831M 81M
Pacira PCRX:US USD 542.92M 112.9M
PTC Therapeutics PTCT:US USD 1.25B 21.18M
Puma Biotechnology PBYI:US USD 98.62M 316K
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Takeda 4502:JP JPY 4.04T 127.86B